Navigation Links
Moffitt Cancer Center researchers analyze how Spanish smoking relapse booklets are distributed
Date:5/16/2013

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre" ("Forever Free"), a Spanish smoking relapse prevention booklet series.

Their analysis found that 10 agencies distributed the booklets actively and passively, but those methods may not have helped the material reach its intended audience, Spanish-speaking smokers who have quit but are at risk for relapse.

Their study appeared in a March issue of the Journal of Cancer Education.

"Previous research suggests that although the current smoking rates among Hispanics are lower than the overall prevalence in the United States, Hispanic smokers are less likely to quit successfully or to use smoking cessation aids," said study co-author Vani Nath Simmons, Ph.D., assistant member of the Health Outcomes and Behavior Program at Moffitt. "Consequently, there is a great need to increase the availability of culturally relevant tobacco information in Spanish. The first aim of this study was to evaluate the distribution process of 'Libres para Siempre' to identify the strategies, methods and barriers to distribution. Secondly, we wanted feedback from the agencies on the booklets' quality and usefulness."

The researchers noted that the relapse rate for self-quitters is 95 to 98 percent and that Hispanic smokers are less likely than their non-Hispanic white counterparts to be advised to quit smoking.

"Forever Free," a series of self-help booklets developed at Moffitt to help smokers, who have quit from relapsing, was found to be cost effective and beneficial for reducing smoking relapse among English speakers. To increase its reach to more diverse populations, the "Forever Free" booklets were adapted to create a culturally appropriate Spanish version, "Libres para Siempre." This study examined how health care and social service agencies in Florida disseminated those Spanish booklets.

"To truly make an impact, we needed to make sure the booklets were getting into the hands of the intended audience," Simmons said.

Active distribution included in-person presentation of the booklets at community events or use of the booklet as part of counseling or tobacco-related classes. Passive distribution included displaying the booklet at agency lobbies, events and health fairs.

There were barriers to optimal distribution. For example, the booklets are a set of eight. Some agencies distributed booklets individually. Some distributors gave booklets to those who may have been interested in quitting smoking, rather than those who had quit and were likely to relapse. The booklets target those in danger of relapse.

"Understanding how these booklets are used in the real world can lead to future research to test alternative distribution strategies," noted Simmons. "We determined that some agencies were unable to understand the distinction between interventions for initial smoking cessation and intervention as relapse prevention."

In evaluating the quality and usefulness of the booklets, agency representatives found them beneficial for their clients.

The authors concluded that the distribution process for "Libres para Siempre" could serve as a pilot study to evaluate strategies and methods of distribution, and find the best ways to reach those Hispanics needing relapse prevention materials.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Cancer biorepository speeds clinical trials, drug development, Moffitt analysis shows
2. Deficiency in p53 anti-tumor protein delays DNA repair after radiation, Moffitt researchers say
3. Some minorities believe they are less likely to get cancer compared to whites, Moffitt study shows
4. 2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study shows
5. Moffitt Cancer Center researchers discuss new frontiers in breast cancer screening
6. Moffitt Cancer Center researchers say 1 specific microrna promotes tumor growth and cancer spread
7. Moffitt Researchers help lead international efforts that find new genetic links to ovarian cancer
8. Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
9. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
10. Genetic risk strategies needed for young, black, female breast cancer patients, Moffitt study shows
11. Moffitt Cancer Center researchers study use of dasatinib for patients with high-risk MDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology: